Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PHILIP EDWARD LAMMERS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1780802330
CMS profile
80658
Location
BARTLETT, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$9,636.16

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $3,447.55 8
E.R. Squibb & Sons, L.L.C. $2,002.64 4
Bristol Myers Squibb Company $1,950.00 1
Merck Sharp & Dohme LLC $155.17 7
Celgene Corporation $149.73 7
Genentech USA, Inc. $145.03 8
GENZYME CORPORATION $138.18 5
Eisai Inc. $131.81 6
Gilead Sciences, Inc. $122.01 6
Pharmacyclics LLC, An AbbVie Company $113.25 6
Seagen Inc. $81.93 3
PFIZER INC. $81.09 5
Rigel Pharmaceuticals, Inc. $76.76 5
Lilly USA, LLC $76.62 3
TerSera Therapeutics LLC $64.58 3
Novartis Pharmaceuticals Corporation $64.50 3
Daiichi Sankyo Inc. $63.42 3
Janssen Biotech, Inc. $53.69 3
SERVIER PHARMACEUTICALS LLC $53.10 3
G1 Therapeutics, Inc. $48.51 3
Puma Biotechnology, Inc. $48.22 3
BeiGene USA, Inc. $46.16 2
Amgen Inc. $44.98 3
Mirati Therapeutics, Inc. $40.17 2
Stemline Therapeutics Inc. $37.98 2
Incyte Corporation $36.10 2
Takeda Pharmaceuticals U.S.A., Inc. $32.88 1
GlaxoSmithKline, LLC. $30.77 2
Regeneron Healthcare Solutions, Inc. $30.10 1
Sumitomo Pharma America, Inc. $29.14 1
Deciphera Pharmaceuticals Inc. $25.32 1
Astellas Pharma US Inc $20.48 1
Genmab U.S., Inc. $19.06 1
PharmaEssentia USA Corporation $18.61 1
Kite Pharma, Inc. $17.34 1
Sun Pharmaceutical Industries Inc. $17.12 1
Exelixis Inc. $16.81 1
Apellis Pharmaceuticals, Inc. $16.25 1
Coherus Biosciences Inc. $15.75 1
AVEO Pharmaceuticals, Inc. $15.62 1
MorphoSys, US Inc. $15.47 1
TAIHO ONCOLOGY, INC. $14.90 1
Bayer Healthcare Pharmaceuticals Inc. $14.26 1
CTI BioPharma Corp. $13.10 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $9,636.16 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $600.0012/12/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014182651 CMS
Merck Sharp & Dohme LLC $28.8512/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048551939 CMS
Puma Biotechnology, Inc. $14.7012/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059057719 CMS
Novartis Pharmaceuticals Corporation $28.0011/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992260501 CMS
Daiichi Sankyo Inc. $19.5811/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006549095 CMS
Gilead Sciences, Inc. $25.4911/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025620671 CMS
PFIZER INC. $18.6111/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050617831 CMS
Rigel Pharmaceuticals, Inc. $12.3711/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261033438609 CMS
Janssen Biotech, Inc. $19.6511/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026988746553 CMS
Lilly USA, LLC $27.7411/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032098475 CMS
Eisai Inc. $17.7111/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261023327219 CMS
Daiichi Sankyo Inc. $23.3011/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006534271 CMS
Novartis Pharmaceuticals Corporation $19.6511/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026992260487 CMS
E.R. Squibb & Sons, L.L.C. $17.2310/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015592697 CMS
Gilead Sciences, Inc. $18.4210/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025877929 CMS
Sumitomo Pharma America, Inc. $29.1410/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261030870917 CMS
PFIZER INC. $13.9110/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050569649 CMS
MorphoSys, US Inc. $15.4710/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261060328519 CMS
Pharmacyclics LLC, An AbbVie Company $16.0110/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998289311 CMS
GlaxoSmithKline, LLC. $15.8010/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261001506969 CMS
AstraZeneca Pharmaceuticals LP $14.5610/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015843380 CMS
PharmaEssentia USA Corporation $18.6110/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059318607 CMS
Rigel Pharmaceuticals, Inc. $18.1810/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261033434483 CMS
Merck Sharp & Dohme LLC $16.5309/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048551785 CMS
GENZYME CORPORATION $24.9809/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261050085829 CMS
Celgene Corporation $25.2009/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015592681 CMS
BeiGene USA, Inc. $22.8309/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051179973 CMS
Pharmacyclics LLC, An AbbVie Company $20.2409/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026998289309 CMS
Bristol Myers Squibb Company $1,950.0009/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015592757 CMS
E.R. Squibb & Sons, L.L.C. $1,950.0009/12/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015592761 CMS
Genentech USA, Inc. $18.2609/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040505123 CMS
Gilead Sciences, Inc. $16.2109/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261025956089 CMS
AstraZeneca Pharmaceuticals LP $11.5909/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014513027 CMS
G1 Therapeutics, Inc. $16.3109/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261059917223 CMS
SERVIER PHARMACEUTICALS LLC $20.4709/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261055092227 CMS
Daiichi Sankyo Inc. $20.5409/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261006488237 CMS
Amgen Inc. $15.0908/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020655817 CMS
Apellis Pharmaceuticals, Inc. $16.2508/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056324921 CMS
Lilly USA, LLC $21.9908/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261032121893 CMS
Deciphera Pharmaceuticals Inc. $25.3208/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261053719277 CMS
Sun Pharmaceutical Industries Inc. $17.1208/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261053944943 CMS
Merck Sharp & Dohme LLC $25.0608/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048551955 CMS
E.R. Squibb & Sons, L.L.C. $19.6908/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015592665 CMS
Mirati Therapeutics, Inc. $20.3208/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261057995871 CMS
Genmab U.S., Inc. $19.0608/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261051347277 CMS
AVEO Pharmaceuticals, Inc. $15.6208/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049064075 CMS
Merck Sharp & Dohme LLC $17.5308/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261048551789 CMS
Seagen Inc. $24.2708/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026995799219 CMS
Incyte Corporation $15.1608/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261044627379 CMS
Stemline Therapeutics Inc. $19.4308/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261040035417 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,562.71 70
PY2020 $5,329.83 22
PY2021 $5,379.29 5
PY2022 $17,879.72 112
PY2023 $9,636.16 125
PY2024 $49,174.19 195
PY2025 $65,938.69 193

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
PHILIP EDWARD LAMMERS, NPI 1780802330. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1780802330.
APA 7
IndustryPayments. (2026). PHILIP EDWARD LAMMERS, NPI 1780802330 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1780802330
Bluebook
PHILIP EDWARD LAMMERS, NPI 1780802330, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1780802330.

Source: Centers for Medicare & Medicaid Services, Open Payments.